Acanthamoeba species from a post-covid patient with CSF rhinorrhea; a next possible post covid menace? A case report.
Indian J Med Microbiol
; 2022 Oct 13.
Article
in English
| MEDLINE | ID: covidwho-2265883
ABSTRACT
A case of Acanthamoeba rhinorrhea in a 32 years female, who was recently recovered from COVID-19 infectionat a tertiary care institute in India. Though, there was no standard treatment protocol for management of amoebic-meningo encephalitis. The patient was managed successfully with combination therapy of amphotericin B and miltefosine. Agents having trophicidal and cysticidal activities are used for treatment of CNS Acanthamoeba infection. COVID 19 infection, steroid therapy anddiabetes mellitus which lead to low immunitywere found to be associated contributing factors.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
Topics:
Long Covid
Language:
English
Journal subject:
Microbiology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS